ZELLI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.374
EU - Europa 1.276
AS - Asia 1.067
SA - Sud America 259
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 35
OC - Oceania 4
Totale 5.099
Nazione #
US - Stati Uniti d'America 2.326
SG - Singapore 498
RU - Federazione Russa 396
IE - Irlanda 237
BR - Brasile 220
IT - Italia 199
HK - Hong Kong 155
DE - Germania 148
CN - Cina 137
VN - Vietnam 137
FI - Finlandia 73
GB - Regno Unito 36
BD - Bangladesh 33
SE - Svezia 32
FR - Francia 29
CZ - Repubblica Ceca 25
IN - India 25
CA - Canada 24
JP - Giappone 19
ES - Italia 18
PL - Polonia 18
ZA - Sudafrica 18
BE - Belgio 14
MX - Messico 13
AR - Argentina 12
UA - Ucraina 10
EC - Ecuador 9
VE - Venezuela 8
ID - Indonesia 7
IQ - Iraq 7
NL - Olanda 7
TR - Turchia 6
UY - Uruguay 6
KR - Corea 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
LT - Lituania 4
UZ - Uzbekistan 4
AU - Australia 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
KE - Kenya 3
PH - Filippine 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PK - Pakistan 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
Totale 5.015
Città #
Dallas 421
San Jose 289
Singapore 283
Dublin 235
Chandler 233
Ashburn 210
Hong Kong 152
Santa Clara 110
Council Bluffs 85
New York 79
The Dalles 70
Munich 69
Boardman 68
Jacksonville 60
Los Angeles 55
Moscow 55
L’Aquila 47
Ho Chi Minh City 35
Hanoi 33
Helsinki 32
Beijing 30
São Paulo 30
Princeton 29
Lawrence 28
Turku 26
Rome 24
Brno 23
Wilmington 21
Bremen 20
Columbus 20
Des Moines 20
Kitzingen 20
San Mateo 19
Frankfurt am Main 18
Teramo 18
Tokyo 18
Warsaw 17
Lappeenranta 15
Brussels 14
Lauterbourg 14
Casoria 13
Johannesburg 13
Stockholm 13
Chennai 12
Orem 12
Atlanta 10
Da Nang 9
Fremont 9
Milan 9
Assago 8
Brooklyn 8
London 8
Montreal 8
Ann Arbor 7
Denver 7
Falkenstein 7
Phoenix 7
San Francisco 7
Shanghai 7
Toronto 7
Woodbridge 7
Boston 6
Chicago 6
Dong Ket 6
Haiphong 6
Manchester 6
Mexico City 6
Montevideo 6
Norwalk 6
Poplar 6
Turin 6
Campinas 5
Jakarta 5
Porto Alegre 5
Recife 5
Amsterdam 4
Assisi 4
Curitiba 4
Edinburgh 4
Fortaleza 4
Houston 4
Nuremberg 4
Providence 4
Seoul 4
Sofia 4
Tashkent 4
Washington 4
Ankara 3
Belo Horizonte 3
Brasília 3
Buffalo 3
Bến Tre 3
Caxias do Sul 3
Cedar Knolls 3
Charlotte 3
Cuiabá 3
Erbil 3
Hải Dương 3
Ipatinga 3
Juneau 3
Totale 3.400
Nome #
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 162
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 156
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 155
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 155
Emerging role of isomirs in cancer: State of the art and recent advances 152
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 147
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 146
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 144
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 141
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 140
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 139
Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy 136
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 130
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 127
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 125
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 122
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 121
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 111
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 110
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 110
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 108
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 108
Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer 106
449: Gene-specific methylation profiles in male breast cancer 106
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 104
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores 98
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122 97
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 96
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 93
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 93
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers 93
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 91
The antiquity of hydrocephalus: the first full palaeo-neuropathological description 89
Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer— BRCA: Challenges and Opportunities 87
Metastases risk in thin cutaneous melanoma: Prognostic value of clinical-pathologic characteristics and mutation profile 85
MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas 83
Methylome profiling of BRCA-positive and BRCA-negative MBCs 81
CD44 mRNA expression in hormonally treated and non-treated prostate cancer cases 81
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy 81
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations 77
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance 77
Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy 75
Evaluation of cyp17a1 and cyp1b1 polymorphisms in male breast cancer risk 72
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 72
PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report 69
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy 67
Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers 56
Anthracycline-Free Neoadjuvant Pertuzumab-Trastuzumab-Taxane in Patients with HER2-Positive Early Breast Cancer: Hormone Receptor Status as a Key Determinant of Pathological Complete Response 11
Effect of Osteoblast-Derived Extracellular Vesicles on Osteosarcoma Cells’ Transcriptional Profile: Role of Shuttled miRNAs 9
null 5
Totale 5.099
Categoria #
all - tutte 22.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022143 0 4 0 1 24 1 5 8 13 3 9 75
2022/2023685 38 52 18 76 48 81 3 39 281 3 37 9
2023/2024281 19 9 21 7 13 79 1 37 2 18 9 66
2024/20251.144 34 23 74 55 128 93 156 130 151 104 111 85
2025/20262.596 136 235 387 303 260 120 325 80 224 357 102 67
2026/2027114 65 49 0 0 0 0 0 0 0 0 0 0
Totale 5.099